Regeneron Pharmaceuticals Inc Cash Flow Reinvestment Rate
Regeneron Pharmaceuticals Inc cash flow reinvestment rate. Regeneron Pharmaceuticals Inc (REGN) has a Cash Flow Reinvestment Rate of 0.76x as of June 2026, reinvesting $438.70 Million (capex $240.20 Million plus investments $198.50 Million) from operating cash flow of $574.50 Million. See financial flexibility index of Regeneron Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Regeneron Pharmaceuticals Inc (2006–2025)
Cash flow reinvestment rate of Regeneron Pharmaceuticals Inc from 2006 to 2025. Historical reinvestment intensity for Regeneron Pharmaceuticals Inc across 16 annual periods. Explore how well can Regeneron Pharmaceuticals Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Regeneron Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (2006–2025)
Regeneron Pharmaceuticals Inc cash flow reinvestment rate by year from 2006 to 2025. Year-by-year capital reinvestment analysis for Regeneron Pharmaceuticals Inc. For the full cash flow conversion analysis, see Regeneron Pharmaceuticals Inc (REGN) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.30x | $1.49 Billion | $4.98 Billion | $898.40 Million | ▼ -59.1% |
| 2024 | 0.73x | $3.22 Billion | $4.42 Billion | $755.90 Million | ▼ -43.2% |
| 2023 | 1.28x | $5.90 Billion | $4.59 Billion | $926.40 Million | ▲ +154.9% |
| 2022 | 0.50x | $2.53 Billion | $5.01 Billion | $590.10 Million | ▼ -33.7% |
| 2021 | 0.76x | $5.38 Billion | $7.08 Billion | $551.90 Million | ▲ +71.8% |
| 2020 | 0.44x | $1.16 Billion | $2.62 Billion | $614.60 Million | ▼ -47.0% |
| 2019 | 0.83x | $2.03 Billion | $2.43 Billion | $429.60 Million | ▲ +26.1% |
| 2018 | 0.66x | $1.45 Billion | $2.20 Billion | $383.10 Million | ▼ -13.9% |
| 2017 | 0.77x | $1.01 Billion | $1.31 Billion | $272.60 Million | ▲ +9.2% |
| 2016 | 0.70x | $1.05 Billion | $1.49 Billion | $511.90 Million | ▲ +3.3% |
| 2015 | 0.68x | $907.60 Million | $1.33 Billion | $677.93 Million | ▲ +22.0% |
| 2014 | 0.56x | $420.78 Million | $752.43 Million | $333.01 Million | ▼ -7.4% |
| 2013 | 0.60x | $355.45 Million | $588.60 Million | $156.32 Million | ▼ -86.4% |
| 2010 | 4.44x | $428.21 Million | $96.34 Million | $99.69 Million | ▲ +559.5% |
| 2007 | 0.67x | $18.45 Million | $27.37 Million | $18.45 Million | ▲ +453.2% |
| 2006 | 0.12x | $2.81 Million | $23.07 Million | $2.81 Million | — |